Hussman Strategic Advisors, Inc. Incyte Corp Transaction History
Hussman Strategic Advisors, Inc.
- $407 Million
- Q2 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 63,000 shares of INCY stock, worth $4.94 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
63,000
Previous 52,500
20.0%
Holding current value
$4.94 Million
Previous $3.18 Million
34.99%
% of portfolio
1.05%
Previous 0.83%
Shares
8 transactions
Others Institutions Holding INCY
# of Institutions
707Shares Held
195MCall Options Held
564KPut Options Held
317K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.41 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.67 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.57 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.17 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$787 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $17.4B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...